Cargando…
A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sp...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599399/ https://www.ncbi.nlm.nih.gov/pubmed/34189670 http://dx.doi.org/10.1007/s12015-021-10204-z |
_version_ | 1784600944002990080 |
---|---|
author | Yu, Hwan Yeul Shin, Jung Hyun Yun, HongDuck Ryu, Chae-Min Lee, Seungun Heo, Jinbeom Lim, Jisun Park, Juhyun Hong, Ki-Sung Chung, Hyung-Min Shin, Dong-Myung Choo, Myung-Soo |
author_facet | Yu, Hwan Yeul Shin, Jung Hyun Yun, HongDuck Ryu, Chae-Min Lee, Seungun Heo, Jinbeom Lim, Jisun Park, Juhyun Hong, Ki-Sung Chung, Hyung-Min Shin, Dong-Myung Choo, Myung-Soo |
author_sort | Yu, Hwan Yeul |
collection | PubMed |
description | BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sprague–Dawley rats were divided into five groups (n = 10). The DUA groups underwent 30 bilateral repetitions of endothelial injury to the iliac arteries to induce CBI, while the sham control group underwent a sham operation. All rats used in this study received a 1.25% cholesterol diet for 8 weeks. M-MSCs at a density of 2.5, 5.0, or 10.0 × 10(5) cells (250 K, 500 K, or 1000 K; K = a thousand) were injected directly into the bladder 7 weeks post-injury, while the sham and DUA group were treated only with vehicle (phosphate buffer solution). One week after M-MSC injection, awake cystometry was performed on the rats. Then, the bladders were harvested, studied in an organ bath, and prepared for histological and gene expression analyses. RESULTS: CBI by iliac artery injury reproduced voiding defects characteristic of DUA with decreased micturition pressure, increased micturition interval, and a larger residual volume. The pathological DUA properties were improved by M-MSC treatment in a dose-dependent manner, with the 1000 K group producing the best efficacy. Histological analysis revealed that M-MSC therapy reduced CBI-induced injuries including bladder fibrosis, muscular loss, and apoptosis. Transplanted M-MSCs mainly engrafted as vimentin and NG2 positive pericytes rather than myocytes, leading to increased angiogenesis in the CBI bladder. Transcriptomes of the CBI-injured bladders were characterized by the complement system, inflammatory, and ion transport-related pathways, which were restored by M-MSC therapy. CONCLUSIONS: Single injection of M-MSCs directly into the bladder of a CBI-induced DUA rat model improved voiding profiles and repaired the bladder muscle atrophy in a dose-dependent manner. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-021-10204-z. |
format | Online Article Text |
id | pubmed-8599399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85993992021-11-24 A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia Yu, Hwan Yeul Shin, Jung Hyun Yun, HongDuck Ryu, Chae-Min Lee, Seungun Heo, Jinbeom Lim, Jisun Park, Juhyun Hong, Ki-Sung Chung, Hyung-Min Shin, Dong-Myung Choo, Myung-Soo Stem Cell Rev Rep Article BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sprague–Dawley rats were divided into five groups (n = 10). The DUA groups underwent 30 bilateral repetitions of endothelial injury to the iliac arteries to induce CBI, while the sham control group underwent a sham operation. All rats used in this study received a 1.25% cholesterol diet for 8 weeks. M-MSCs at a density of 2.5, 5.0, or 10.0 × 10(5) cells (250 K, 500 K, or 1000 K; K = a thousand) were injected directly into the bladder 7 weeks post-injury, while the sham and DUA group were treated only with vehicle (phosphate buffer solution). One week after M-MSC injection, awake cystometry was performed on the rats. Then, the bladders were harvested, studied in an organ bath, and prepared for histological and gene expression analyses. RESULTS: CBI by iliac artery injury reproduced voiding defects characteristic of DUA with decreased micturition pressure, increased micturition interval, and a larger residual volume. The pathological DUA properties were improved by M-MSC treatment in a dose-dependent manner, with the 1000 K group producing the best efficacy. Histological analysis revealed that M-MSC therapy reduced CBI-induced injuries including bladder fibrosis, muscular loss, and apoptosis. Transplanted M-MSCs mainly engrafted as vimentin and NG2 positive pericytes rather than myocytes, leading to increased angiogenesis in the CBI bladder. Transcriptomes of the CBI-injured bladders were characterized by the complement system, inflammatory, and ion transport-related pathways, which were restored by M-MSC therapy. CONCLUSIONS: Single injection of M-MSCs directly into the bladder of a CBI-induced DUA rat model improved voiding profiles and repaired the bladder muscle atrophy in a dose-dependent manner. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-021-10204-z. Springer US 2021-06-29 2021 /pmc/articles/PMC8599399/ /pubmed/34189670 http://dx.doi.org/10.1007/s12015-021-10204-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yu, Hwan Yeul Shin, Jung Hyun Yun, HongDuck Ryu, Chae-Min Lee, Seungun Heo, Jinbeom Lim, Jisun Park, Juhyun Hong, Ki-Sung Chung, Hyung-Min Shin, Dong-Myung Choo, Myung-Soo A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title | A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title_full | A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title_fullStr | A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title_full_unstemmed | A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title_short | A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia |
title_sort | preclinical study of human embryonic stem cell-derived mesenchymal stem cells for treating detrusor underactivity by chronic bladder ischemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599399/ https://www.ncbi.nlm.nih.gov/pubmed/34189670 http://dx.doi.org/10.1007/s12015-021-10204-z |
work_keys_str_mv | AT yuhwanyeul apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT shinjunghyun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT yunhongduck apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT ryuchaemin apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT leeseungun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT heojinbeom apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT limjisun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT parkjuhyun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT hongkisung apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT chunghyungmin apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT shindongmyung apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT choomyungsoo apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT yuhwanyeul preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT shinjunghyun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT yunhongduck preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT ryuchaemin preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT leeseungun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT heojinbeom preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT limjisun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT parkjuhyun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT hongkisung preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT chunghyungmin preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT shindongmyung preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia AT choomyungsoo preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia |